Molecular Biology

p.17 A.A. Levin, L.J. Sturzenbecker, S. Kazmer, T. Bosakowski, C. Huselton, G. Allenby, J. Speck, C. Kratzeisen, M. Rosenberger, A. Lovey, J.F. Grippo, "9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRa," Nature, 355:359-61, 1992. Arthur A. Levin and Joseph F. Grippo (Department of Toxicology and Pathology, Hoffmann-La Roche Inc., Nutley, N.J.): "The biologic activities of the all-trans (t) isomer of retinoic acid (RA) are mediated through the binding and activati

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

p.17

A.A. Levin, L.J. Sturzenbecker, S. Kazmer, T. Bosakowski, C. Huselton, G. Allenby, J. Speck, C. Kratzeisen, M. Rosenberger, A. Lovey, J.F. Grippo, "9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRa," Nature, 355:359-61, 1992.

Arthur A. Levin and Joseph F. Grippo (Department of Toxicology and Pathology, Hoffmann-La Roche Inc., Nutley, N.J.): "The biologic activities of the all-trans (t) isomer of retinoic acid (RA) are mediated through the binding and activation of a family of nuclear RA receptors (RARs) that are members of the steroid/thyroid superfamily of ligand- dependent transcription factors. A second family of nuclear RA receptors, the RXRs, was discovered that were weakly activated by t-RA but did not directly bind this ligand (D.J. Mangelsdorf, et al., Nature, 345:224-9, 1990 and Hot Papers, The Scientist, Nov. 25, 1991, page 16). These results suggested that a t-RA metabolite was the proximate ligand for the RXRs, and we ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies